Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,979 | -10,418 | -18,495 | -44,303 | -11,273 |
| Depreciation Amortization | 189 | 166 | 121 | 1,223 | 1,400 |
| Accounts receivable | -169 | -3 | -11 | 12 | 15 |
| Accounts payable and accrued liabilities | 294 | 19 | 120 | -68 | 85 |
| Other Working Capital | 29 | 515 | 14 | 325 | 572 |
| Other Operating Activity | 407 | 3,291 | 12,338 | 39,482 | 7,237 |
| Operating Cash Flow | $-8,230 | $-6,430 | $-5,913 | $-3,330 | $-1,964 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 621 | 3,423 | -12,960 | N/A | N/A |
| PPE Investments | -106 | -171 | -265 | -31 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -175 | N/A | N/A |
| Other Investing Activity | 0 | 0 | -175 | 0 | 0 |
| Investing Cash Flow | $515 | $3,252 | $-13,400 | $-31 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 250 | 4,290 |
| Common Stock Issued | 7,528 | 2,349 | N/A | 21,073 | 10 |
| Other Financing Activity | -149 | 0 | 0 | 0 | 727 |
| Financing Cash Flow | $7,379 | $2,349 | $N/A | $21,323 | $5,027 |
| Beginning Cash Position | 884 | 1,714 | 21,027 | 3,065 | 2 |
| End Cash Position | 548 | 884 | 1,714 | 21,027 | 3,065 |
| Net Cash Flow | $-337 | $-829 | $-19,313 | $17,962 | $3,063 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,230 | -6,430 | -5,913 | -3,330 | -1,964 |
| Capital Expenditure | -106 | -171 | -265 | -31 | N/A |
| Free Cash Flow | -8,337 | -6,601 | -6,178 | -3,361 | -1,964 |